Institutional Fund
Sands Capital Alternatives, LLC
Arlington, VACIK 18464445 filings on record
Portfolio Value
$421.20M
Q1 2026
Holdings
21
Reported positions
New Buys
1
Opened this quarter
QoQ Change
-18.8%
from $518.47M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Nu Hldgs Ltd22.3%
- Klaviyo Inc16.9%
- Spyglass Pharma Inc15.4%
- Beta Bionics Inc8.8%
- Inhibikase Therapeutics Inc5.2%
- Coupang Inc4.5%
- Other26.9%
Portfolio Holdings
21 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Nu Hldgs Ltd | 6.54M | $93.95M | 22.3% | −323.6K | Reduced |
| 2 | Klaviyo Inc | 3.65M | $71.02M | 16.9% | 0 | Held |
| 3 | Spyglass Pharma Inc | 2.50M | $64.78M | 15.4% | +2.50M | New |
| 4 | Beta Bionics Inc | 3.71M | $37.15M | 8.8% | +137.9K | Added |
| 5 | Inhibikase Therapeutics Inc | 13.02M | $21.87M | 5.2% | 0 | Held |
| 6 | Coupang Inc | 1.01M | $19.11M | 4.5% | +141.7K | Added |
| 7 | Samsara Inc | 560.3K | $17.76M | 4.2% | +94.1K | Added |
| 8 | Doordash Inc | 111.2K | $16.70M | 4.0% | +15.6K | Added |
| 9 | Bioage Labs Inc | 786.4K | $13.75M | 3.3% | 0 | Held |
| 10 | 10x Genomics Inc | 481.8K | $10.23M | 2.4% | 0 | Held |
11 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio